Total submissions: 1
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Ambry Genetics | RCV004616073 | SCV005104787 | uncertain significance | Inborn genetic diseases | 2024-03-29 | criteria provided, single submitter | clinical testing | The c.4886T>A (p.F1629Y) alteration is located in exon 33 (coding exon 33) of the CUBN gene. This alteration results from a T to A substitution at nucleotide position 4886, causing the phenylalanine (F) at amino acid position 1629 to be replaced by a tyrosine (Y). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. |